Lab Reagents
Antibody Elisa Laboratories manufactures the bispecific antibody elisa reagents distributed by Genprice. The Bispecific Antibody Elisa reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact antibody elisa. Other Bispecific products are available in stock. Specificity: Bispecific Category: Antibody Group: Elisa
Anti-Claudin-18 Isoform2-Anti-CD3 IgG Bispecific Antibody |
|||
| 101541-2 | BPS Bioscience | 100 µg | EUR 490 |
|
Description: Anti-Claudin-18 isoform2 (CLDN18.2)-Anti-CD3 IgG format bispecific antibody is a purified recombinant human bispecific antibody with T cell Engager. This bispecific antibody has been tested for specific activity in the functional reporter assay using NFAT-luc reporter Jurkat cell line (BPS Bioscience #60621) in the presence of CLDN18.2-CHO cells (BPS Bioscience #78533-H) that overexpress CLDN18.2. |
|||
Recombinant Anti-Ang2 x Anti-VEGFA Bispecific Antibody (Bi-nanobody) |
|||
| BIVHH-008 | Creative Biolabs | 200μg | Ask for price |
|
Description: A bispecific antibody that is expressed as an anti-Ang2 nanobody (VHH) fused with an anti-VEGFA nanobody (VHH), contains a His-tag at the C/N terminus for affinity purification. This BsAb is capable of inhibiting two proangiogenics fators. It is designed for the research of Colorectal cancer (CRC); Solid tumors; Wet AMD (Age-related macular degeneration); Diabetic macular edema therapy. |
|||
Recombinant Anti-IL17A x Anti-IL17F Bispecific Antibody (Bi-nanobody) |
|||
| BIVHH-176 | Creative Biolabs | 200μg | Ask for price |
|
Description: A bispecific antibody that is expressed as an anti-IL17A nanobody (VHH) fused with an anti-IL17F nanobody (VHH), contains a His-tag at the C/N terminus for affinity purification. This BsAb can block two proinflammatory cytokines simultaneously. It is designed for the research of Multiple sclerosis (MS); Autoimmune diseases; Inflammatory diseases therapy. |
|||
Recombinant Anti-EGFR x Anti-CD3 Bispecific Antibody (Tandem scFv) |
|||
| BSFV-077-50ug | Creative Biolabs | 50μg | EUR 2446.8 |
|
Description: A bispecific antibody that is expressed as an anti-EGFR scFv fused with an anti-CD3 scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can retarget T cells to tumor cells. It is designed for the research of Head and neck cancer; Colorectal cancer (CRC); Glioblastoma multiforme (GBM); Squamous cancer; Glioblastoma; Medulloblastoma; Non-small cell lung cancer (NSCLC); Renal cell cancer (RCC); Solid tumors therapy. |
|||
Recombinant Anti-EPCAM x Anti-CD3 Bispecific Antibody (Tandem scFv) |
|||
| BSFV-079-100ug | Creative Biolabs | 100μg | EUR 4272 |
|
Description: A bispecific antibody that is expressed as an anti-EPCAM scFv fused with an anti-CD3 scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can retarget T cells to tumor cells. It is designed for the research of Solid tumors therapy. |
|||
Recombinant Anti-EPCAM x Anti-CD3 Bispecific Antibody (Tandem scFv) |
|||
| BSFV-079-50ug | Creative Biolabs | 50μg | EUR 2446.8 |
|
Description: A bispecific antibody that is expressed as an anti-EPCAM scFv fused with an anti-CD3 scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can retarget T cells to tumor cells. It is designed for the research of Solid tumors therapy. |
|||
Recombinant Anti-CD3 x Anti-PSMA Bispecific Antibody (Tandem scFv) |
|||
| BSFV-102-100ug | Creative Biolabs | 100μg | EUR 4272 |
|
Description: A bispecific antibody that is expressed as an anti-CD3 scFv fused with an anti-PSMA scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can retarget T cells to tumor cells. It is designed for the research of Prostate cancer therapy. |
|||
Recombinant Anti-CD3 x Anti-PSMA Bispecific Antibody (Tandem scFv) |
|||
| BSFV-102-50ug | Creative Biolabs | 50μg | EUR 2446.8 |
|
Description: A bispecific antibody that is expressed as an anti-CD3 scFv fused with an anti-PSMA scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can retarget T cells to tumor cells. It is designed for the research of Prostate cancer therapy. |
|||
Recombinant Anti-FIXa x Anti-FX Bispecific Antibody (Tandem scFv) |
|||
| BSFV-162-100ug | Creative Biolabs | 100μg | EUR 4552.8 |
|
Description: A bispecific antibody that is expressed as an anti-FIXa scFv fused with an anti-FX scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can bind and dimerize two factors. It acts as mimetic FXIII. It is designed for the research of Hemophilia A therapy. |
|||
Recombinant Anti-FIXa x Anti-FX Bispecific Antibody (Tandem scFv) |
|||
| BSFV-162-50ug | Creative Biolabs | 50μg | EUR 2587.2 |
|
Description: A bispecific antibody that is expressed as an anti-FIXa scFv fused with an anti-FX scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can bind and dimerize two factors. It acts as mimetic FXIII. It is designed for the research of Hemophilia A therapy. |
|||
Recombinant Anti-BSA x Anti-CD3 Bispecific Antibody (Tandem scFv) |
|||
| BSFV-c001-100ug | Creative Biolabs | 100μg | EUR 4552.8 |
|
Description: A bispecific antibody that is expressed as an anti-BSA scFv fused with an anti-CD3 scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can be used as a negative control to other anti-CD3 BsAbs in the research of tumor therapy. |
|||
Recombinant Anti-BSA x Anti-CD3 Bispecific Antibody (Tandem scFv) |
|||
| BSFV-c001-50ug | Creative Biolabs | 50μg | EUR 2587.2 |
|
Description: A bispecific antibody that is expressed as an anti-BSA scFv fused with an anti-CD3 scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can be used as a negative control to other anti-CD3 BsAbs in the research of tumor therapy. |
|||
Recombinant Anti-HER2 x Anti-mCD3 Bispecific Antibody (KIH-IgG) |
|||
| BSAB-002-100ug | Creative Biolabs | 100μg | EUR 4833.6 |
|
Description: A bispecific antibody that is consisted of one half of anti-human HER2 IgG and one hlaf of anti-mouse CD3 IgG.his BsAb is designed to explore the effect of the anti-HER2 antibody in mouse model. |
|||
Recombinant Anti-HER2 x Anti-mCD3 Bispecific Antibody (KIH-IgG) |
|||
| BSAB-002-50ug | Creative Biolabs | 50μg | EUR 3008.4 |
|
Description: A bispecific antibody that is consisted of one half of anti-human HER2 IgG and one hlaf of anti-mouse CD3 IgG.his BsAb is designed to explore the effect of the anti-HER2 antibody in mouse model. |
|||
Recombinant Anti-CD2 x Anti-EGFR Bispecific Antibody (Tandem Fab) |
|||
| BSFAB-046-100ug | Creative Biolabs | 100μg | EUR 4693.2 |
|
Description: A bispecific antibody that is expressed as an anti-CD2 Fd region fused to an anti-EGFR Fd region. The two Fd regions are connected by a flexible linker. This BsAb can retarget T cells to tumor cells. It is designed for the research of Head and neck cancer; Colorectal cancer (CRC); Glioblastoma multiforme (GBM); Squamous cancer; Glioblastoma; Medulloblastoma; Non-small cell lung cancer (NSCLC); Renal cell cancer (RCC); Solid tumors therapy. |
|||
Recombinant Anti-CD2 x Anti-EGFR Bispecific Antibody (Tandem Fab) |
|||
| BSFAB-046-50ug | Creative Biolabs | 50μg | EUR 2868 |
|
Description: A bispecific antibody that is expressed as an anti-CD2 Fd region fused to an anti-EGFR Fd region. The two Fd regions are connected by a flexible linker. This BsAb can retarget T cells to tumor cells. It is designed for the research of Head and neck cancer; Colorectal cancer (CRC); Glioblastoma multiforme (GBM); Squamous cancer; Glioblastoma; Medulloblastoma; Non-small cell lung cancer (NSCLC); Renal cell cancer (RCC); Solid tumors therapy. |
|||
Recombinant Anti-BCMA x Anti-CD3 Bispecific Antibody (Tandem scFv) |
|||
| BSFV-020-100ug | Creative Biolabs | 100μg | EUR 4272 |
|
Description: A bispecific antibody that is expressed as an anti-BCMA scFv fused with an anti-CD3 scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can retarget T cells to tumor cells and is designed for the research of Multiple myeloma (MM) therapy. |
|||